A novel use for novel acute kidney injury biomarkers fenoldopams effect on neutrophil gelatinase-associated lipocalin and cystatin C.docVIP

Goldstein Critical Care 2011,15:177 /content/15/4/177 COMMENTARY A novel use for novel acute kidney injury biomarkers: fenoldopam’s e? ect on neutrophil gelatinase-associated lipocalin and cystatin C Stuart L Goldstein* See related research by Ricci et al., /content/15/3/R160 (NGAL) and cystatin C, in a novel manner to de? ne AKI Abstract rather than predict AKI [1]. In their randomized trial, the Substantial basic and translational research has been directed to detect earlier and more sensitive acute kidney injury (AKI) biomarkers over the past decade. Much of the seminal AKI biomarker